Mediclin AG (MED.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap175.75M
Enterprise Value494.4M
P/E Ratio6.76
PEG Ratio0.61
Price/Sales Ratio0.24
Price/Book Ratio0.81
Enterprise/Revenue0.63
Enterprise/EBITDA11.7

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.04
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.12

Income Statement

Revenue784.49M
Revenue/Share15.6
Gross Profit113.81M
EBITDA98.66M
Net Income25.49M
Diluted EPS0.54

Balance Sheet

Total Cash152.4M
Total Cash/Share3.02
Total Debt384.07M
Total Debt/Equity1.52
Current Ratio1.74
Book Value Per Share5.02

Price History

52-Week Change39.31
52-Week High4.26
52-Week Low2.86
Moving Average 50 Days3.87
Moving Average 200 Days3.67

Statistics

Average Volume7,723
Shares Outstanding47.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.99
Payout Ratio0.07
Last Split FactorN/A
Last Split DateN/A
AD